Form 8-K - Current report:
SEC Accession No. 0001193125-25-025324
Filing Date
2025-02-13
Accepted
2025-02-12 21:16:11
Documents
13
Period of Report
2025-02-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d933627d8k.htm   iXBRL 8-K 42543
  Complete submission text file 0001193125-25-025324.txt   162614

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ibrx-20250207.xsd EX-101.SCH 2856
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ibrx-20250207_lab.xml EX-101.LAB 17235
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ibrx-20250207_pre.xml EX-101.PRE 10816
15 EXTRACTED XBRL INSTANCE DOCUMENT d933627d8k_htm.xml XML 3501
Mailing Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121
Business Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121 (844) 696-5235
ImmunityBio, Inc. (Filer) CIK: 0001326110 (see all company filings)

EIN.: 431979754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37507 | Film No.: 25616858
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)